Clinical trial
Evaluation of the AFP Model in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation in Patients Without Microvascular Invasion.
NCT03775863 is registered in ClinicalTrials.gov with Austral University, Argentina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the AFP Model in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation in Patients Without Microvascular Invasion.
- Lead sponsor
- Austral University, Argentina
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 11, 2017
- Completion date
- December 12, 2018
- Enrollment
- 1,200 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
liver carcinoma, liver transplant disorder